This compound is a pharmaceutical intermediate featuring an amide functional group attached to a heterocyclic ring system, with moderate polarity and low lipophilicity as indicated by its physicochemical profile. Its primary significance lies in its use as a chemical building block for the production of more complex pharmaceutical agents.
Alcance del contenido: La información de esta página se refiere a la identificación química y a los contextos de suministro industrial, investigación y producción. No constituye una afirmación terapéutica, un consejo médico ni instrucciones de uso de medicamentos.
¿Adquiriendo o suministrando este compuesto?
Publique su inventario o una solicitud de compra
CAS 136738-23-3
(Z)-Benzyl 7-((1R,2R,3R,5S)-2-(4,4-difluoro-3-hydroxyoctyl)-5-hydroxy-3-((tetrahydro-2H-pyran-2-yl)oxy)cyclopentyl)hept-5-enoate
pharmaceutical intermediate
Potassium vinyltrifluoroborate
pharmaceutical intermediate
N-[9-[(2R,3R,4R,5R)-5-[[bis(4-methoxyphenyl)-phenylmethoxy]methyl]-4-[2-cyanoethoxy-[di(propan-2-yl)amino]phosphanyl]oxy-3-fluorooxolan-2-yl]purin-6-yl]benzamide
Pharmaceutical intermediate for oligonucleotide synthesis
4-(4-HYDROXYMETHYL-3-METHOXYPHENOXY)-BUTYRIC ACID
HMPB linker for solid-phase peptide synthesis
4-Amino-6-methyl-4,5-dihydro-1,2,4-triazin-3(2H)-one--hydrogen chloride (1/1)
Pharmaceutical intermediate
N-(6-methyl-3-oxo-2,5-dihydro-1,2,4-triazin-4-yl)acetamide
NCSCAWXVGUIUEY-UHFFFAOYSA-N
CC1=NNC(=O)N(C1)NC(=O)C
—